Xeriant Inc Financials
This page shows Xeriant Inc (XERI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 16 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Xeriant Inc passes 1 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).
For every $1 of reported earnings, Xeriant Inc generates $0.78 in operating cash flow (-$1.3M OCF vs -$1.6M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
Xeriant Inc earns $-6.1 in operating income for every $1 of interest expense (-$1.4M vs $226K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Xeriant Inc's EBITDA was -$1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 28.4% from the prior year.
Xeriant Inc generated -$1.3M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 9.8% from the prior year.
Xeriant Inc reported -$1.6M in net income in fiscal year 2025. This represents an increase of 46.9% from the prior year.
Xeriant Inc earned $0.00 per diluted share (EPS) in fiscal year 2025. This represents an increase of 100.0% from the prior year.
Xeriant Inc held $45K in cash against $3K in long-term debt as of fiscal year 2025.
Xeriant Inc had 696M shares outstanding in fiscal year 2025. This represents an increase of 32.6% from the prior year.
Xeriant Inc invested $69K in research and development in fiscal year 2025. This represents a decrease of 64.7% from the prior year.
Xeriant Inc invested $2K in capex in fiscal year 2025, funding long-term assets and infrastructure.
XERI Income Statement
| Metric | Q2'26 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | $16K-69.8% | $54K+78.6% | $30K+201393.3% | $15-99.9% | $27K-60.7% | $68K+28.0% | $53K+95.5% | $27K |
| SG&A Expenses | $28K+13.9% | $25K-75.6% | $102K-29.9% | $146K+158.0% | $56K-17.4% | $68K-6.2% | $73K+39.0% | $52K |
| Operating Income | $231K+176.0% | -$304K+33.7% | -$459K-36.8% | -$336K+6.5% | -$359K-1.7% | -$353K-3.8% | -$340K-6.6% | -$319K |
| Interest Expense | $36K-20.0% | $45K-32.3% | $66K+28.8% | $51K-16.6% | $62K+115.7% | $29K-96.6% | $847K+3995.3% | $21K |
| Income Tax | $16K-87.2% | $125K | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $298K-86.6% | $2.2M+521.9% | -$528K-28.7% | -$410K-10.2% | -$372K+1.1% | -$376K+68.6% | -$1.2M-250.6% | -$342K |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | N/A |
XERI Balance Sheet
| Metric | Q2'26 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | N/A | $72K-2.0% | $73K-73.5% | $277K-22.0% | $355K-21.5% | $452K+250.2% | $129K-49.7% | $257K |
| Current Assets | N/A | $62K-0.4% | $62K-76.9% | $269K-16.0% | $320K-17.8% | $389K+628.9% | $53K-68.2% | $168K |
| Cash & Equivalents | N/A | $52K-2.7% | $54K-78.9% | $254K-15.3% | $300K-19.7% | $374K+858.3% | $39K+58.8% | $25K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | N/A | $2.9M-49.9% | $5.8M-5.0% | $6.1M+1.8% | $6.0M-30.5% | $8.6M+8.0% | $8.0M+11.5% | $7.2M |
| Current Liabilities | N/A | $5.8M-33.3% | $8.7M-7.1% | $9.3M | N/A | $8.6M+8.5% | $7.9M+11.4% | $7.1M |
| Long-Term Debt | N/A | $2K | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | N/A | -$2.8M+50.6% | -$5.7M+1.7% | -$5.8M-3.3% | -$5.6M+31.0% | -$8.2M-4.0% | -$7.8M-13.8% | -$6.9M |
| Retained Earnings | N/A | -$26.1M+6.8% | -$28.0M-1.9% | -$27.5M-1.5% | -$27.1M-6.0% | -$25.5M-1.5% | -$25.2M-5.0% | -$24.0M |
XERI Cash Flow Statement
| Metric | Q2'26 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $383K+315.7% | -$178K+51.4% | -$366K+8.1% | -$398K-12.7% | -$353K+15.0% | -$415K-23.5% | -$336K-9.2% | -$308K |
| Capital Expenditures | N/A | N/A | N/A | $0 | N/A | $0 | $0 | $0 |
| Free Cash Flow | N/A | N/A | N/A | -$370K | N/A | -$415K-23.5% | -$336K-9.2% | -$308K |
| Investing Cash Flow | N/A | $0 | $0 | $0 | $0 | $0+100.0% | -$419K-202.0% | $411K |
| Financing Cash Flow | $415K+124.3% | $185K+12.1% | $165K-53.1% | $352K | $0-100.0% | $750K-2.6% | $770K+650.2% | -$140K |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
XERI Financial Ratios
| Metric | Q2'26 | Q1'25 | Q3'25 | Q2'24 | Q1'24 | Q3'24 | Q2'23 | Q1'23 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | 3103.4%+3824.5pp | -721.1%-572.9pp | -148.3%-43.4pp | -104.9%-21.6pp | -83.3%+846.2pp | -929.5%-796.3pp | -133.3% |
| Current Ratio | N/A | 0.010.0 | 0.01-0.1 | 0.07 | N/A | 0.05+0.0 | 0.01-0.0 | 0.02 |
| Debt-to-Equity | N/A | -0.00+1.0 | -1.01+0.0 | -1.05+0.0 | -1.060.0 | -1.06-0.0 | -1.02+0.0 | -1.04 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$5.8M), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Note: The current ratio is below 1.0 (0.01), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.
Similar Companies
Frequently Asked Questions
Is Xeriant Inc profitable?
No, Xeriant Inc (XERI) reported a net income of -$1.6M in fiscal year 2025.
What is Xeriant Inc's earnings per share (EPS)?
Xeriant Inc (XERI) reported diluted earnings per share of $0.00 for fiscal year 2025. This represents a 100.0% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.
What is Xeriant Inc's EBITDA?
Xeriant Inc (XERI) had EBITDA of -$1.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Xeriant Inc have?
As of fiscal year 2025, Xeriant Inc (XERI) had $45K in cash and equivalents against $3K in long-term debt.
What is Xeriant Inc's free cash flow?
Xeriant Inc (XERI) generated -$1.3M in free cash flow during fiscal year 2025. This represents a 9.8% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Xeriant Inc's operating cash flow?
Xeriant Inc (XERI) generated -$1.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Xeriant Inc's total assets?
Xeriant Inc (XERI) had $68K in total assets as of fiscal year 2025, including both current and long-term assets.
What are Xeriant Inc's capital expenditures?
Xeriant Inc (XERI) invested $2K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Xeriant Inc spend on research and development?
Xeriant Inc (XERI) invested $69K in research and development during fiscal year 2025.
How many shares does Xeriant Inc have outstanding?
Xeriant Inc (XERI) had 696M shares outstanding as of fiscal year 2025.
What is Xeriant Inc's current ratio?
Xeriant Inc (XERI) had a current ratio of 0.01 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.
What is Xeriant Inc's debt-to-equity ratio?
Xeriant Inc (XERI) had a debt-to-equity ratio of -0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Xeriant Inc's return on assets (ROA)?
Xeriant Inc (XERI) had a return on assets of -2414.1% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Xeriant Inc's cash runway?
Based on fiscal year 2025 data, Xeriant Inc (XERI) had $45K in cash against an annual operating cash burn of $1.3M. This gives an estimated cash runway of approximately 0 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.
Why is Xeriant Inc's debt-to-equity ratio negative or unusual?
Xeriant Inc (XERI) has negative shareholder equity of -$5.8M as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
What is Xeriant Inc's Piotroski F-Score?
Xeriant Inc (XERI) has a Piotroski F-Score of 1 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Xeriant Inc's earnings high quality?
Xeriant Inc (XERI) has an earnings quality ratio of 0.78x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Xeriant Inc cover its interest payments?
Xeriant Inc (XERI) has an interest coverage ratio of -6.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.